SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-19-000195
Filing Date
2019-08-09
Accepted
2019-08-09 15:22:47
Documents
41
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 q2finalvedgar1.htm 10-Q 403948
2 exhibit31vedgar1.htm EX-31 6683
3 exhibit32vedgar1.htm EX-32 3241
  Complete submission text file 0001551163-19-000195.txt   1696152

Data Files

Seq Description Document Type Size
4 bion-20190630.xml EX-101.INS 248769
5 bion-20190630.xsd EX-101.SCH 20302
6 bion-20190630_cal.xml EX-101.CAL 32075
7 bion-20190630_def.xml EX-101.DEF 33328
8 bion-20190630_lab.xml EX-101.LAB 130113
9 bion-20190630_pre.xml EX-101.PRE 106420
Mailing Address 21-2 CAMELLIA, 5 JALAN KERINCHI KUALA LUMPUR N8 59200
Business Address 21-2 CAMELLIA, 5 JALAN KERINCHI KUALA LUMPUR N8 59200 60122126512
BioNexus Gene Lab Coporation (Filer) CIK: 0001737523 (see all company filings)

IRS No.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-229399 | Film No.: 191012777
SIC: 8071 Services-Medical Laboratories